Portrait of Gabriella McCarty

Gabriella McCarty,

MSN, NP-C

Gabriella McCarty,

MSN, NP-C
Nurse Practitioner, North Shore Gastroenterology

Gabriella McCarty,

Portrait of Gabriella McCarty
MSN, NP-C

Nurse Practitioner, North Shore Gastroenterology

Gabriella McCarty, MSN, NP-C, is a gastroenterology/hepatology nurse practitioner. She obtained her master’s and nurse practitioner degree at Case Western Reserve University in 2004. She has been practicing in this field for 24 years and serves as faculty for Gastroenterology/Hepatology Advanced Practice Providers and is an American College of Gastroenterology committee member. She loves all aspects gastroenterology/hepatology, education, and nursing.

Gabriella's Shared Resources

Asia people young woman video call talk chat help guide online at home by AI tele consult telehealth telemedicine app clinic in IoT device collect ECG data heart pulse sleep rate on cloud computing.

Telemedicine in Opioid Treatment Programs Boosts Hepatitis C Cure Rates and Reduces Drug Use

Researchers of this study compared hepatitis C cure rates in those receiving care at opioid treatment programs through facilitated telemedicine...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

HCV Treatment Reduces Cardiovascular, Renal, and Ocular Risks in Patients Who are Diabetic

Researchers of this study investigated the impact of successful hepatitis C virus (HCV) treatment on long-term complications in patients with...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

Global HCV in Dialysis: 24.3% Prevalence Demands Urgent Action

A systematic review and meta-analysis involving 634 studies across 392,160 patients revealed a global hepatitis C virus (HCV) prevalence of...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

HCV Guidelines Emphasize Universal Screening, Simplified Treatment, and Global Access

Hepatitis C virus (HCV) remains a global health challenge, despite direct-acting antivirals achieving cure rates over 95%. In the United...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

Modern Antiviral Treatments for HCV Achieve More Than 98% Cure Rates

Decades ago, in the 1970s, cases of transfusion-associated hepatitis, called non-A, non-B hepatitis (NANBH), were often chronic, but the cause...
CURATED BY:
Gabriella McCarty,
MSN, NP-C

UK’s 2030 Hepatitis Elimination Strategy

Hepatitis B and C viruses remain leading causes of disability and premature death worldwide. In May 2016, the UK adopted...
CURATED BY:
Gabriella McCarty,
MSN, NP-C
Share